Dose Escalation Study of EG110A, Administered by Intradetrusor Injections to Adults With Neurogenic Detrusor Overactivity-related Incontinence Following Spinal Cord Injury Who Regularly Perform Clean Intermittent Catheterization

PHASE1/PHASE2RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 8, 2025

Primary Completion Date

April 30, 2027

Study Completion Date

April 30, 2027

Conditions

Neurogenic Detrusor OveractivitySpinal Cord Injuries

Interventions

DRUG

EG110A

Participants treated with EG110A

Trial Locations (4)

RECRUITING

Sidney Kimmel Medical College, Philadelphia

RECRUITING

University of Michigan Rogel Cancer Center, Ann Arbor

RECRUITING

UTHealth Houston / TIRR Memorial Hermann, Houston

RECRUITING

Rancho Los Amigos National Rehabilitation Center, Downey